D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Corteva
CTVA
$59.7B
| $370K | ﹤0.01% |
+4,971
| New | +$331K |
|
|
SLI
3652
Standard Lithium
SLI
$517M
| $370K | ﹤0.01% |
188,916
+24,060
| +15% | +$37.9K |
|
3653
CALL
Caleres
CAL
$396M
| $370K | ﹤0.01% |
30,300
+10,000
| +49% | +$150K |
|
3654
Mercantile Bank Corp
MBWM
$1.01B
| $369K | ﹤0.01% |
7,944
-1,147
| -13% | -$49.7K |
|
3655
PUT
Coca-Cola
KO
$354B
| $368K | ﹤0.01% |
5,200
-135,800
| -96% | -$9.67M |
|
3656
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.19B
| $367K | ﹤0.01% |
9,766
-4,093
| -30% | -$147K |
|
3657
KB Home
KBH
$3.48B
| $366K | ﹤0.01% |
6,917
-1,680
| -20% | -$89.3K |
|
3658
NovoCure
NVCR
$2.04B
| $366K | ﹤0.01% |
+20,556
| New | +$358K |
|
3659
CALL
Huntsman Corp
HUN
$2.24B
| $365K | ﹤0.01% |
+35,000
| New | +$426K |
|
3660
Tecnoglass
TGLS
$2.01B
| $364K | ﹤0.01% |
+4,700
| New | +$365K |
|
3661
PUT
J.M. Smucker
SJM
$12.6B
| $363K | ﹤0.01% |
+3,700
| New | +$407K |
|
|
GES
3662
PUT
DELISTED
Guess Inc
GES
| $363K | ﹤0.01% |
30,000
-35,000
| -54% | -$391K |
|
3663
PUT
Ally Financial
ALLY
$13.1B
| $362K | ﹤0.01% |
9,300
-77,200
| -89% | -$2.67M |
|
3664
South Plains Financial
SPFI
$841M
| $361K | ﹤0.01% |
10,024
-2,614
| -21% | -$89.9K |
|
3665
Healthcare Realty
HR
$7.42B
| $361K | ﹤0.01% |
22,760
-29,014
| -56% | -$441K |
|
|
API
3666
Agora
API
$326M
| $360K | ﹤0.01% |
94,386
| – | – |
|
3667
EPAM Systems
EPAM
$4.69B
| $357K | ﹤0.01% |
2,020
-72,861
| -97% | -$12.2M |
|
3668
Vera Therapeutics
VERA
$2.54B
| $357K | ﹤0.01% |
+15,154
| New | +$341K |
|
3669
Safe Bulkers
SB
$781M
| $356K | ﹤0.01% |
98,659
-92,226
| -48% | -$330K |
|
3670
CALL
indie Semiconductor
INDI
$733M
| $356K | ﹤0.01% |
100,000
| – | – |
|
3671
Highwoods Properties
HIW
$3.71B
| $356K | ﹤0.01% |
11,437
-23,202
| -67% | -$683K |
|
3672
CALL
Virgin Galactic
SPCE
$320M
| $355K | ﹤0.01% |
130,000
| – | – |
|
3673
State Street SPDR Dow Jones REIT ETF
RWR
$1.93B
| $355K | ﹤0.01% |
3,679
-3,107
| -46% | -$298K |
|
3674
US Foods
USFD
$21.4B
| $355K | ﹤0.01% |
4,606
-8,994
| -66% | -$642K |
|
3675
Core Laboratories
CLB
$538M
| $354K | ﹤0.01% |
30,738
-17,614
| -36% | -$209K |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.